Study of the physiological role and the diagnostic/ prognostic value of novel molecular tumor biomarkers (Kallikreins, DDC, CEAL, SR-A1, BCL2L12).
Molecular cloning, characterization and clinical study of newly discovered human genes and miRNAs, which could be used as molecular markers or therapeutic targets.
Development of hypersensitive molecular and immunochemical methods.
Development of novel molecular methodologies for prediction of chemotherapy response in cancer cells.